Weaver C. Barksdale & Associates, Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1294588 NASHVILLE, TN

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,140,073

-$228,241 QoQ

Shares Held

16,939

-0.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.92%

of 13F equity value

Holder Rank

#809

of 2,266 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Weaver C. Barksdale & Associates, Inc. holds $10,562,339 across 6 Drug Manufacturers - General names. GILD ranks #2 (20.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	9,898	$2,490,732
2	GILD	Gilead Sciences, Inc. This page	16,939	$2,140,073
3	AMGN	Amgen Inc	5,857	$2,120,936
4	MRK	Merck & Co., Inc.	10,979	$1,410,801
5	JNJ	Johnson & Johnson	5,202	$1,321,151
6	BMY	Bristol Myers Squibb Co	18,720	$1,078,646

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,140,073	16,939	-0.3%	Shares	Sole	2026-08-14
2026-03-31	$2,368,314	16,993	-4.4%	Shares	Sole	2026-05-14
2025-12-31	$2,181,212	17,771	-10.3%	Shares	Sole	2026-02-13
2025-09-30	$2,198,133	19,803	-6.0%	Shares	Sole	2025-11-12
2025-06-30	$2,336,030	21,070	-0.4%	Shares	Sole	2025-08-12
2025-03-31	$2,369,857	21,150	-10.6%	Shares	Sole	2025-05-14
2024-12-31	$2,185,012	23,655	-2.5%	Shares	Sole	2025-02-12
2024-09-30	$2,034,629	24,268	-3.7%	Shares	Sole	2024-11-13
2024-06-30	$1,729,589	25,209	-1.3%	Shares	Sole	2024-08-13
2024-03-31	$1,871,244	25,546	-0.8%	Shares	Sole	2024-05-14
2023-12-31	$2,085,683	25,746	-20.9%	Shares	Sole	2024-02-13
2023-09-30	$2,437,948	32,532	+19.3%	Shares	Sole	2023-11-14
2023-06-30	$2,101,930	27,273	-5.8%	Shares	Sole	2023-08-14
2023-03-31	$2,402,230	28,953	-3.8%	Shares	Sole	2023-05-12
2022-12-31	$2,584,428	30,104	+2.8%	Shares	Sole	2023-02-14
2022-09-30	$1,806,838	29,289	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.